POLICY IMPLEMENTATION OF HALAL PRODUCT ASSURANCE FOR PHARMACEUTICAL PRODUCTS IN INDONESIA

Hilyatul Fadliyah, Atik Nurwahyuni

Abstract


After the implementation of halal product assurance (HPA) became a public policy, the assurance for halal pharmaceutical products is a must. However, the implementation has been relaxed for several years. This shows that the policy implementation is complicated. This study aimed to analyze and evaluate the implementation process of the HPA policy for pharmaceutical products in Indonesia. We applied Van Meter Van Horn’s theory using the qualitative method through in-depth interviews with eight informants and a review ten documents. The result shows that the implementation is going well but is still not optimal, especially from the point of view regarding halal certification for pharmaceutical products. The main obstacle for business actors in this implementation is obtaining halal raw materials because most of them are still imported. Moreover, a lack of massive socialization and education have also appeared. All stakeholders involved should improve performance according to their respective duties to implement better when the obligation has begun.

Keywords


Halal Product Assurance; Pharmaceutical Products; Policy Implementation

Full Text:

PDF

References


Kementerian Agama. Data umat berdasar jumlah pemeluk agama; 2018; cited 2022 June 5. Available from: https://web.archive.org/web/20201113145319/ https://data.kemenag.go.id/statistik/agama

Zakaria Z, Abdullah MA. The enforcement activities under post-market control of halal certification in Malaysia. Halal Journal. 2019; 3.

Majlis Ugama Islam Singapura. Singapore halal certification [homepage on the Internet]; 2020. Available from: https://www.muis.gov.sg/Halal/About .

Ridwan AH. Authorization of halal certification in Indonesia, Malaysia and Singapore. International Journal of Psychosocial Rehabilitation. 2020; 24(08): 7992-8011.

Singapore Statutes Online. Administration of Muslim Law Act 1966 [homepage on the Internet]; 2022. Available from: https://sso.agc.gov.sg/act/amla1966 .

Department of Standards Malaysia. MS 2424:2012 – Halal pharmaceuticals - general guideline [homepage on the Internet]; 2012. Available from: https://www.jsm.gov.my/ms-2424-2012-halal-pharmaceuticals-general-guidelines#.YpysinYzbIU .

Santoso, Yusuf I. Wajib halal, industri farmasi masih kebingungan; 2016 [updated 2016 August 30; cited 2022 April 9]. Available from: https://industri.kontan.co.id/news/wajib-hahal-industri-farmasi-masih-kebingungan .

Kementerian Perindustrian. Bahan baku obat di Indonesia 90% masih impor; 2015 [updated 2015 May 28; cited 2022 April 9]. Available from: https://www.kemenperin.go.id/artikel/12156/Bahan-Baku-Obat-di-Indonesia-90-Masih-Impor .

Peraturan Pemerintah Nomor 31 Tahun 2019 tentang Peraturan Pelaksanaan Undang- Undang-Undang No. 33 Tahun 2014 tentang Jaminan Produk Halal.

Peraturan Menteri Agama Nomor 26 Tahun 2019 tentang Penyelenggaraan Jaminan Produk Halal.

Van Meter DSVM, Van Horn CE. The implementation of intergovernmental policy. In S. S. Nagel (Ed.), Policy Studies Review Annual - Google Books (Vol. 1, p. 103) [monograph on the internet]. Transaction Publishers; 1977 [cited 2022 April 9]. Available from: https://books.google.co.id/books?hl=en&lr=&id=tR-MBck8t0YC&oi=fnd&pg=PA97&dq .

Ayuningtyas D. Analisis kebijakan kesehatan prinsip dan aplikasi. 1st ed. Raja Grafindo Persada; 2018.

Badan Penyelenggara Jaminan Produk Halal [homepage on the Internet]; 2021. Available from: http://halal.go.id/

Faridah HD. Halal certification in Indonesia; history, development, and implementation. Journal of Halal Product and Research. 2019; 2(2): 68-78.

Rachman FF, Pramana S. Analisis sentimen pro dan kontra masyarakat Indonesia tentang vaksin COVID-19 pada media sosial Twitter. Health Information Management Journal. 2020, 8(2), 100–109.

Agustino L. Dasar-dasar Kebijakan Publik (Edisi Revisi). 7th ed. Alfabeta; 2019.

Komite Nasional Keuangan Syariah. Masterplan ekonomi syariah Indonesia 2019-2024; 2018 [updated 2015 May 28; cited 2022 April 9]. Available from: https://knks.go.id/storage/upload/1573459280-Masterplan Eksyar_Preview.pdf

Wulansari H, Anggraini AMT. Perlindungan konsumen terhadap ketiadaan label halal pada produk farmasi menurut Undang-Undang Nomor 33 Tahun 2014 Tentang Jaminan Produk Halal. Jurnal Hukum Adigama. 2018, 1(1), 1062–1086.

Lembaga Pengkajian Pangan Obat-obatan dan Kosmetika Majelis Ulama Indonesia. Kondisi dan tantangan industri farmasi dalam sertifikasi halal; 2020 [updated 2021 April 16; cited 2022 April 9]. Available from: https://www.halalmui.org/mui14/main/detail/kondisi-dan-tantangan-industri-farmasi-dalam-sertifikasi-halal .

Nurani N, Nursjanti F, Munawar F. Penyuluhan Sertifikasi Halal Bagi UMKM Jawa Barat Pada Situasi Pandemi Covid-19. Madaniya. 2020, 1(3), 126–139. https://madaniya.pustaka.my.id/journals/contents/article/view/24

Lembaga Pengkajian Pangan Obat-obatan dan Kosmetika Majelis Ulama Indonesia. Webinar halal series LPPOM MUI: Obat halal, darurat sampai kapan? [video]; 2021 [updated 2021 March 24; cited 2022 April 9]. Available from: https://www.youtube.com/watch?v=gwXThll5X4s .

Arini WE. Analisis Implementasi Kebijakan Kemandirian dan Pengembagan Bahan Baku Obat dalam Peraturan Menteri Kesehatan Republik Indonesia Nomor 17 Tahun 2017 [tesis]. Depok: Fakultas Kesehatan Masyarakat, Universitas Indonesia; 2019.

Sitanggang ML. Kebijakan dan regulasi kemandirian bahan baku obat; 2016 [presented at the UNPAD Pharmaceutical Raw Materials Independence Pentahelix Seminar].




DOI: http://dx.doi.org/10.7454/ihpa.v7i2.5856

Refbacks

  • There are currently no refbacks.